Professor Dudley Sinnett MS FRCS - Chairman from January 2018
Previously a Professor of Breast Surgery at Imperial College London, Dudley’s first Consultant post was as Senior Lecturer at the Institute of Cancer Research and honorary Consultant Surgeon at the Royal Marsden Hospital. From 1989 to 2009 he worked at Charing Cross Hospital and, whilst there, became Consultant Breast Surgeon and Director of Breast Services. He has been the Quality Assurance Surgeon for the surgical aspects of the National Breast Screening programme in London. Dudley has been the national secretary of the British Association of Surgical Oncology and helped produce the national surgical guidelines for the treatment of breast cancer and serving on the BASO national committee. He has previously been a member of the Medical Advisory Committee of Breast Cancer Care and has published a number of papers on breast disease and DVDs for the BMA and the National Breast Screening programme. Dudley first joined our Board of Trustees in 2007 and became our Chairman in January 2018. 

Peter Bell
Peter Bell is a specialist in branding and engagement and has worked for high profile blue chip companies including Unilever, Whitbread and BSkyB. He was a founder director of the business coaching company The Coaching House and then became a director and major shareholder of the Added Value Group, helping it grow in to one of the world’s largest marketing consultancies. Following Added Value’s sale to WPP he ran the global engagement practice for The Brand Union until starting his own consultancy Bell Brand Engagement. He is a Fellow of the Marketing Society and a non-executive director of La Chispa.


Dorinda Hickey
Dorinda has had a long career in senior roles within the pharmaceutical industry. Graduating with a PhD in Haematology from Trinity College, Dublin, she started her career as a research assistant at St James’s Hospital, Dublin, before moving to Sandoz UK and subsequently Novartis in a variety of sales, marketing, business intelligence and general management roles. In 2005, Dorinda moved into consultancy and was founding partner of Navigate Health LLP, working for both pharmaceutical industry and NHS clients. Dorinda has clinical research and commercial experience in a wide variety of therapy areas including oncology, haematology and dermatology. She has recently completed a master’s degree in Health Economics, Policy and Management at the London School of Economics and Political Science.


Alastair is Vice Chairman of the Board of Breast Cancer Haven since September 2017.  He is Founder and Chairman of Naisbitt King Asset Management Limited (NKAML), an independent, FCA-regulated fund management firm, headquartered in the City of London. Alastair was elected as Alderman of the Ward of Queenhithe in the City of London, in November 2016.

Alastair is European Education Chairman (2016-2018) of the Young President’s Organisation (YPO), the world’s premier peer network of young chief executives, Co-Chair of the YPO London Star Chapter and Chairman of the Haringey Project for “On-Side” – a leading provider of youth clubs (“Youth Zones”) in deprived metropolitan areas.


Ms Pippa Lambert is currently Global Head of HR for the Deutsche Bank, with responsibility for the Bank’s worldwide Human Resources organisation. She was the Director of Global Reward at the Royal Bank of Scotland from 2011-2013. Prior to that, Ms Lambert held several positions with Deutsche Bank. She has recently been appointed as a member of the Senior Salaries Review Board. 




Lord Rockley FCA

Lord Anthony Rockley joined The Haven as a Trustee in 2013. He was a partner of KPMG in London, working exclusively with Private Equity Funds. He joined Peats in 1983 and has remained there ever since. Throughout the 90s he worked extensively in KPMG’s offices in the emerging markets of Eastern Europe, but is now UK based. He lives in Dorset where he divides his spare time between gardening and country sports.

Anthony sits on our Audit Committee and he is a trustee of the Worcester Breast Cancer Haven Board.


Professor Ian Smith has both a private and an NHS practice at The Royal Marsden. He is Professor of Cancer Medicine at The Royal Marsden and the Institute of Cancer Research. He is also Head of the Breast Unit at The Royal Marsden. His initial medical training was in Edinburgh and then he came to The Royal Marsden for specialist training in cancer medicine. He also spent some time in Boston at the Dana-Farber Cancer Institute, Harvard. Over the years his principal clinical research interests have been in breast cancer, lung cancer and new drug development. He was involved in the early clinical development of several anti-cancer drugs that have subsequently proved effective in the clinic, including carboplatin and letrozole.

In the last decade he has become increasingly involved in neoadjuvant (preoperative) therapies as a research approach towards individualised treatments for breast cancer. He is currently Chief Investigator or UK Principal Investigator for several international multicentre breast cancer trials involving in particular targeted therapies and aromatase inhibitors. He publishes and lectures extensively. He was awarded the Susan G Komen for the Cure Brinker Award for Scientific Distinction at the 2009 San Antonio International Breast Cancer Conference.

Professor Smith was recently the first Chairman of the UK Breast Trials Intergroup and Chairman of the British Breast Group. He was the Scientific Chairman of the Breast Section of 2012 ESMO, and he has also chaired several national professional bodies including the Association of Cancer Physicians, the Royal College of Physicians Specialist Advisory Committee for Medical Oncology and the NCRI Lung Cancer Clinical Studies Group. He has just been appointed Co–chairman of the ASCO Clinical Guidelines Group for Chemotherapy in Metastatic Breast Cancer.


Chris Whitworth FCA

Chris took a degree in Economics at University College, London and in 1971 qualified as a Chartered Accountant with a City firm that is now merged with Ernst & Young. In 1972 he moved to Montreal, Canada and worked with KPMG for two years, following which he worked in a variety of financial positions in manufacturing, foreign exchange and consulting engineering. In 1982 he moved to Houston, Texas where he was VP Finance and subsequently President of a geological research company. He returned to the UK in 1987 to join the FCB Advertising group as Group Finance Director, and following the merger of the FCB and Publicis European groups in 1990 he was first UK Group FD for the enlarged Publicis-FCB Group and in 1997 was additionally appointed as Northern Europe FD. In 2000 he joined the Omnicom/DAS-owned WWAV Rapp Collins, the UK’s largest Direct Marketing agency, as Group FD, and in 2003 he moved to his present position as DAS’s International CFO. Chris works extensively with the UK advertising industry trade bodies. He is a Council member and former Hon Treasurer of the IPA, and also a trustee director of the IPA Portable Pension Scheme. He is Chairman of the Finance Committee of the Advertising Association and a director of Asbof.


To contact the Board please write to or email Sally Hall

Breast Cancer Haven, Effie Road, London, SW6 1TB